RHUMBLINE ADVISERS

Position in IPSC — Century Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in IPSC

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$314,589

+$293,992 QoQ

Shares Held

128,404

+196.7% QoQ

Ownership

0.071%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#41

of 98 holders

Holding Since

Sep 2021

15 quarters on record

Voting authority Sole 19% Shared 0% None 81%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,721,264 across 329 Biotechnology names. IPSC ranks #217 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$314,589	128,404	+196.7%	Shares	Sole	2026-08-12
2025-03-31	$20,597	43,273	+0.4%	Shares	Sole	2025-05-29
2024-12-31	$43,521	43,091	-13.6%	Shares	Sole	2025-05-29
2024-09-30	$85,264	49,862	-5.0%	Shares	Sole	2024-11-12
2024-06-30	$133,788	52,466	+56.0%	Shares	Sole	2024-08-01
2024-03-31	$140,606	33,638	+2.1%	Shares	Sole	2024-05-09
2023-12-31	$109,380	32,946	-3.7%	Shares	Sole	2024-02-08
2023-09-30	$68,404	34,202	+2.2%	Shares	Sole	2023-11-09
2023-06-30	$105,708	33,452	+7.6%	Shares	Sole	2023-08-08
2023-03-31	$107,923	31,102	+1.2%	Shares	Sole	2023-05-11
2022-12-31	$157,691	30,739	+0.7%	Shares	Sole	2023-02-14
2022-09-30	$301,813	30,517	+6.8%	Shares	Sole	2022-11-10
2022-06-30	$240,055	28,578	+91.0%	Shares	Sole	2022-08-11
2022-03-31	$188,358	14,961	+72.0%	Shares	Sole	2022-05-12
2021-09-30	$218,816	8,697	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.